Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram N Ganapathi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Gynecologic Oncology|February 7, 2018
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapyKatherine R Miller, Jai N Patel, Qing Zhang, et al.
Neoplasia (New York, N.Y.)|February 22, 2018
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian CancerMandy Stanske, Stephan Wienert, Dan Cacsire Castillo-Tong, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumIlary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Gynecologic Oncology|February 7, 2018
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapyKatherine R Miller, Jai N Patel, Qing Zhang, et al.
Neoplasia (New York, N.Y.)|February 22, 2018
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian CancerMandy Stanske, Stephan Wienert, Dan Cacsire Castillo-Tong, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumIlary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Pageof 2